Is it a Good Time to Buy Aphria Inc. (TSX:APH) or HEXO Inc. (TSX:HEXO) Stock?

Aphria Inc. (TSX:APH)(NYSE:APH) and HEXO Corp. (TSX:HEXO) are potential takeover targets in the cannabis sector. Is one a better bet right now?

| More on:
time is money compounding

Cannabis stocks have roared back to life in 2019, and investors who missed the rally in the pot stock market in recent weeks are wondering which marijuana stocks might be the best buys today.

Let’s take a look at Aphria (TSX:APH)(NYSE:APH) and HEXO (TSX:HEXO) to see if one deserves to be in your portfolio.

Aphria

Aphria has likely been the pot stock most discussed around the water cooler in recent months. The action began with a short-seller report that claimed Aphria had significantly overpaid for acquisitions in made in South America.

The news initially sent the stock into a free fall at a time when the entire sector was already in retreat after the disappointing roll-out to the Canadian recreational marijuana market. Aphria’s stock dropped from its closing price of $10.50 per share at the end of November to a low of $5 on December 5. Since then, the share price has trended higher, and the recent surge took it above $14.

What happened?

A takeover attempt by U.S.-based Green Growth Brands helped bring investors back into the mix. The bid likely provided support for the perceived value of Aphria’s broader business and stoked hopes of a potential takeover battle, as Aphria refused the overtures. The concurrent widespread rally in the cannabis sector also helped.

Where we go from here is anyone’s guess. At the time of writing, Aphria trades for $12.50 per share, giving the company a market capitalization of just over $3 billion. It still hasn’t announced a major alliance with a global tobacco or beverage company, so any news on that front could send the shares even higher.

If the overall business is sound, one of the larger peers might decide to step in and buy Aphria before the next leg to the upside. Canopy Growth, for example, has a market capitalization of $21 billion right now, so the deal would be possible.

HEXO

HEXO is an interesting player in the cannabis market. With a current market capitalization of $1.4 billion, the company is relatively small in comparison to the handful of other high-profile players, but it is positioned well to capture a fair chunk of the Canadian and European medical marijuana market through its facility expansions.

HEXO is the leading supplier to Quebec, and its partnership with Molson Coors Canada also puts it in good shape to compete once the sale of consumables goes live in Canada.

Consolidation is expected to continue in the cannabis industry, and HEXO would likely be an attractive target for its strong Quebec presence and the leg up it has on some competitors in the development of cannabis-infused beverages.

Is one a better bet?

Aphria has a history of making big acquisitions, so it isn’t a surprise it pushed back against the Green Growth takeover, and management could even decide to take a run at HEXO. Whether or not that is on the radar is yet to be seen, but it would give the company a stronger Canada-wide presence and instantly provide a key beverage partnership. That said, Aphria has had a massive run in the past few weeks, and a large pullback might be on the way as investors book profits.

All of the cannabis stocks appear expensive, so investors should be cautious. If you are convinced the upward trend has legs through the rest of 2019, I would probably make HEXO the first pick of the two stocks.

If you are not optimistic on the outlook for cannabis stocks, other opportunities are worth considering in the market today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Walker has no position in the companies mentioned. The Motley Fool owns shares of Molson Coors Brewing.

More on Investing

BCE stock
Tech Stocks

10% Yield: Is BCE Stock a Good Buy?

The yield is bigger than it's ever been in the company's history. That might not be a good thing.

Read more »

3 colorful arrows racing straight up on a black background.
Investing

1 Canadian Stock Ready to Surge Into 2025

Canadian Natural Resources (TSX:CNQ) stock is a sleeping dividend giant that may be about to wake up.

Read more »

Tractor spraying a field of wheat
Investing

Is Nutrien Stock a Buy for its 4.7% Dividend Yield?

Nutrien (TSX:NTR) is a well-known defensive commodities play. But is this stock worth buying for its dividend yield alone?

Read more »

Happy shoppers look at a cellphone.
Tech Stocks

So You Own Shopify Stock: Is it Still a Good Investment?

Shopify (TSX:SHOP) stock has had a run, but there's still room to the upside.

Read more »

Paper Canadian currency of various denominations
Investing

The Best Stocks to Invest $2,000 in Right Now

Do you have some extra cash to spare? Here are three Canadian stocks to add to your watch list today.

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Friday, November 22

Continued gains in gold, oil, and natural gas prices could give the commodity-focused TSX benchmark a boost at the opening…

Read more »

Train cars pass over trestle bridge in the mountains
Dividend Stocks

Is CNR Stock a Buy, Sell, or Hold for 2025?

Can CNR stock continue its long-term outperformance into 2025 and beyond? Let's explore whether now is a good time to…

Read more »

engineer at wind farm
Energy Stocks

Invest $20,000 in This Dividend Stock for $100 in Monthly Passive Income

This dividend stock has it all – a strong outlook, monthly income, and even more to consider buying today.

Read more »